Literature DB >> 18356286

Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1/3.

Dana L Fox1, Deborah J Good.   

Abstract

Mechanisms controlling body weight involve gene regulation through the activation of signal transduction pathways. The Janus kinase/signal transducer and activator of transcription (STAT) signal transduction pathway is the mechanism primarily used by leptin in the hypothalamus. The transcription factor nescient helix-loop-helix 2 (Nhlh2) is a downstream target of leptin signaling and is expressed in proopiomelanocortin arcuate neurons. Proopiomelanocortin is cleaved by prohormone convertase 1/3 (PC1/3) to produce peptides that regulate the body's response to energy availability. Previous studies show that the PC1/3 promoter contains STAT3 sites mediating leptin-induced PC1/3 expression, and that Nhlh2 is required for hypothalamic PC1/3 expression because Nhlh2 knockout mice have reduced PC1/3 mRNA levels. Studies herein reveal that leptin-induced PC1/3 gene expression is abrogated in N2KO mice, and that in a hypothalamic cell line both STAT3 and Nhlh2 are required for the full transcriptional response of a PC1/3 reporter gene after leptin stimulation. Furthermore, it is shown that Nhlh2 binds to E-box motifs found adjacent to STAT3 sites in the PC1/3 promoter both in vitro and in chromatin immunoprecipitation assays. Finally, two different protein-protein interaction assays confirm the presence of a STAT3:Nhlh2 heterodimer on the PC1/3 promoter. The Nhlh2:STAT3 heterodimer may be an important transcriptional regulator of other hypothalamic genes in the leptin signaling pathway. These data confirm Nhlh2 as an integral element of the Janus kinase/STAT signaling pathway and are the first to demonstrate coordinated control of PC1/3 transcription by Nhlh2 and STAT3 after leptin stimulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356286      PMCID: PMC2422831          DOI: 10.1210/me.2008-0010

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  34 in total

1.  Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders.

Authors:  Denise D Belsham; Fang Cai; Hong Cui; Simon R Smukler; Anne Marie F Salapatek; Lulzim Shkreta
Journal:  Endocrinology       Date:  2003-10-09       Impact factor: 4.736

2.  Incongruent expression profiles between human and mouse orthologous genes suggest widespread neutral evolution of transcription control.

Authors:  Itai Yanai; Dan Graur; Ron Ophir
Journal:  OMICS       Date:  2004

3.  Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines.

Authors:  Q L Li; E Jansen; T C Friedman
Journal:  Mol Cell Endocrinol       Date:  1999-12-20       Impact factor: 4.102

4.  Reduced voluntary activity precedes adult-onset obesity in Nhlh2 knockout mice.

Authors:  Christopher A Coyle; Enxuan Jing; Trina Hosmer; J Bradley Powers; George Wade; Deborah J Good
Journal:  Physiol Behav       Date:  2002-11

Review 5.  How the brain regulates food intake and body weight: the role of leptin.

Authors:  D G Baskin; J E Blevins; M W Schwartz
Journal:  J Pediatr Endocrinol Metab       Date:  2001       Impact factor: 1.634

6.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.

Authors:  Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

7.  Deletion of the Nhlh2 transcription factor decreases the levels of the anorexigenic peptides alpha melanocyte-stimulating hormone and thyrotropin-releasing hormone and implicates prohormone convertases I and II in obesity.

Authors:  Enxuan Jing; Eduardo A Nillni; Vanesa C Sanchez; Ronald C Stuart; Deborah J Good
Journal:  Endocrinology       Date:  2003-12-30       Impact factor: 4.736

Review 8.  Regulation of prohormone convertases in hypothalamic neurons: implications for prothyrotropin-releasing hormone and proopiomelanocortin.

Authors:  Eduardo A Nillni
Journal:  Endocrinology       Date:  2007-06-21       Impact factor: 4.736

9.  Precursor-protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro-orexin.

Authors:  K N Nilaweera; P Barrett; J G Mercer; P J Morgan
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 10.  Leptin-induced signal transduction pathways.

Authors:  Krisztina Hegyi; Kristóf Fülöp; Krisztina Kovács; Sára Tóth; András Falus
Journal:  Cell Biol Int       Date:  2004       Impact factor: 3.612

View more
  17 in total

1.  Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival.

Authors:  Z Liu; V Stanojevic; S Avadhani; T Yano; J F Habener
Journal:  Diabetologia       Date:  2011-05-13       Impact factor: 10.122

Review 2.  Patterning, specification, and differentiation in the developing hypothalamus.

Authors:  Joseph L Bedont; Elizabeth A Newman; Seth Blackshaw
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-27       Impact factor: 5.814

3.  Two single nucleotide polymorphisms in the human nescient helix-loop-helix 2 (NHLH2) gene reduce mRNA stability and DNA binding.

Authors:  Numan Al Rayyan; Umesh D Wankhade; Korie Bush; Deborah J Good
Journal:  Gene       Date:  2012-09-28       Impact factor: 3.688

4.  Melanocortin 4 receptor is a transcriptional target of nescient helix-loop-helix-2.

Authors:  Umesh D Wankhade; Deborah J Good
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

5.  Leptin signaling regulates hypothalamic expression of nescient helix-loop-helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3).

Authors:  Numan Al Rayyan; Jinhua Zhang; Amy S Burnside; Deborah J Good
Journal:  Mol Cell Endocrinol       Date:  2014-01-29       Impact factor: 4.102

6.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

Review 7.  Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

Authors:  Bharat B Aggarwal; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Shan R Gupta; Sheeja T Tharakan; Cemile Koca; Sanjit Dey; Bokyung Sung
Journal:  Ann N Y Acad Sci       Date:  2009-08       Impact factor: 5.691

8.  Deletion of Nhlh2 results in a defective torpor response and reduced Beta adrenergic receptor expression in adipose tissue.

Authors:  Umesh D Wankhade; Kristen R Vella; Dana L Fox; Deborah J Good
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

9.  Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans.

Authors:  A Kemal Topaloglu; Enver Simsek; Matthew A Kocher; Jamala Mammadova; Ece Bober; Leman Damla Kotan; Ihsan Turan; Can Celiloglu; Fatih Gurbuz; Bilgin Yuksel; Deborah J Good
Journal:  Hum Genet       Date:  2022-01-23       Impact factor: 5.881

10.  The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake.

Authors:  Leona Plum; Hua V Lin; Roxanne Dutia; Jun Tanaka; Kumiko S Aizawa; Michihiro Matsumoto; Andrea J Kim; Niamh X Cawley; Ji-Hye Paik; Y Peng Loh; Ronald A DePinho; Sharon L Wardlaw; Domenico Accili
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.